Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients

Ferric pyrophosphate citrate (FPC) is a water-soluble iron salt administered via dialysate to supply iron directly to transferrin. The PRIME study tested whether treatment with FPC could reduce prescribed erythropoiesis-stimulating agent (ESA) use and maintain hemoglobin in hemodialysis patients. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Ajay, Lin, Vivian, Guss, Carrie, Pratt, Raymond, Ikizler, T Alp, Besarab, Anatole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653585/
https://www.ncbi.nlm.nih.gov/pubmed/26154926
http://dx.doi.org/10.1038/ki.2015.203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653585/
https://www.ncbi.nlm.nih.gov/pubmed/26154926
http://dx.doi.org/10.1038/ki.2015.203

Ejemplares similares